Lymphoma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Lymphoma stocks.

Lymphoma Stocks Recent News

Date Stock Title
May 31 BIIB Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
May 31 BIIB Repligen (RGEN) Down 10.9% Since Last Earnings Report: Can It Rebound?
May 31 BIIB Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
May 31 BIIB How To Invest: Using Shorter-Term Moving Averages To Trade Stocks
May 31 TGTX TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
May 31 BIIB European Commission approves Biogen’s QALSODY for ALS treatment
May 30 BIIB EU approves Biogen treatment for genetic form of ALS
May 30 BIIB Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
May 30 PCRX Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
May 30 TGTX Despite shrinking by US$192m in the past week, TG Therapeutics (NASDAQ:TGTX) shareholders are still up 131% over 5 years
May 30 TEVA Teva wins FDA nod for new Austedo formulation
May 30 TEVA FDA approves Teva Pharmaceuticals’ AUSTEDO XR for TD and HD chorea
May 29 TEVA Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
May 29 BIIB Qiagen (QGEN) Up 1.6% Since Last Earnings Report: Can It Continue?
May 29 BIIB Interim results of IGNAZ trial sheds positive light on felzartamab for IgAN
May 29 KURA Kura Oncology to Participate in Jefferies Global Healthcare Conference
May 29 NRIX Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 28 BGNE BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human Study
May 28 BGNE BriaCell signs supply agreement with BeiGene for metastatic breast cancer treatment
May 28 NEO NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
Lymphoma

Lymphoma is a group of blood cancers that develop from lymphocytes (a type of white blood cell). The name often refers to just the cancerous versions rather than all such tumors. Signs and symptoms may include enlarged lymph nodes, fever, drenching sweats, unintended weight loss, itching, and constantly feeling tired. The enlarged lymph nodes are usually painless. The sweats are most common at night.There are dozens of subtypes of lymphomas. The two main categories of lymphomas are Hodgkin's lymphomas (HL) and the non-Hodgkin lymphomas (NHL). The World Health Organization (WHO) includes two other categories as types of lymphoma: multiple myeloma and immunoproliferative diseases. About 90% of lymphomas are non-Hodgkin lymphomas. Lymphomas and leukemias are a part of the broader group of tumors of the hematopoietic and lymphoid tissues.Risk factors for Hodgkin lymphoma include infection with Epstein–Barr virus and a history of the disease in the family. Risk factors for common types of non-Hodgkin lymphomas include autoimmune diseases, HIV/AIDS, infection with human T-lymphotropic virus, immunosuppressant medications, and some pesticides. Eating large amounts of red meat and tobacco smoking may also increase the risk. Diagnosis, if enlarged lymph nodes are present, is usually by lymph node biopsy. Blood, urine, and bone marrow testing may also be useful in the diagnosis. Medical imaging may then be done to determine if and where the cancer has spread. Lymphoma most often spreads to the lungs, liver, and brain.

Browse All Tags